Postpartum Hemorrhage Clinical Trial
Official title:
The Use of the Bakri Postpartum Balloon in the Management of Postpartum Hemorrhage Refractory to Conservative Measures: A Multi-Site Longitudinal Study An Initiative Under the East African Women's Health Network (EAWoHNet)
The broad objective of the study is to determine if the Bakri Postpartum Balloon is
effective in preventing morbidity and mortality from postpartum hemorrhage (PPH) as part of
a standardized management algorithm.
Specific Objectives
- To estimate the rate of morbidity (including operative intervention and peripartum
hysterectomy) and mortality secondary to PPH in 4 academic centers after introduction
of a standardized protocol for management of PPH, but prior to the inclusion of the
Bakri Postpartum Balloon as part of the protocol.
- To estimate the rate of morbidity (including operative intervention and peripartum
hysterectomy) and mortality secondary to PPH in 4 academic centers after introduction
of a standardized protocol for management of PPH, after the inclusion of the Bakri
Postpartum Balloon as part of the protocol.
- To compare morbidity
- To generate preliminary data for (a) a larger confirmatory study of the use of the
Bakri Postpartum Balloon in centers with surgical and blood transfusion services, and
(b) design of a pilot study of the use of the Bakri device of temporary control of PPH
in settings outside of surgical centers (such as by trained midwives or emergency
transport personnel).
Phase I: Development and training of staff in standardized algorithm for management of PPH
using available local resources (not including Bakri balloon).
Phase II: Data collection after introduction of the standardized algorithm.
Phase III: Revision of protocol to include the Bakri Postpartum Device
Phase IV: Data collection after introduction of the Bakri device
Bakri Postpartum Balloon 510K Premarket Notification/Cook OBGYN #K062438
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03434444 -
In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol
|
N/A | |
Terminated |
NCT01980173 -
Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care
|
N/A | |
Not yet recruiting |
NCT06033170 -
Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage
|
N/A | |
Completed |
NCT02163616 -
Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study
|
Phase 3 | |
Not yet recruiting |
NCT02319707 -
Management of the Third Stage of Labor
|
Phase 3 | |
Recruiting |
NCT01600612 -
Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial
|
N/A | |
Completed |
NCT02079558 -
Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section
|
Phase 2 | |
Withdrawn |
NCT01108302 -
Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India
|
N/A | |
Completed |
NCT00097123 -
RCT of Misoprostol for Postpartum Hemorrhage in India
|
N/A | |
Completed |
NCT02883673 -
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
|
N/A | |
Completed |
NCT02542813 -
Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers
|
Phase 1 | |
Completed |
NCT04201665 -
EMG for Uterotonic Efficiency Estimation
|
N/A | |
Terminated |
NCT03246919 -
Ideal Time of Oxytocin Infusion During Cesarean Section
|
Phase 4 | |
Not yet recruiting |
NCT05501106 -
Reducing Postpartum Hemorrhage After Vaginal Delivery
|
N/A | |
Completed |
NCT05429580 -
Prophylactic Tranexamic Acid Use After Vaginal Delivery
|
N/A | |
Terminated |
NCT03064152 -
Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery
|
N/A | |
Recruiting |
NCT05382403 -
Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage
|
N/A | |
Completed |
NCT02910310 -
Introduction of UBT for PPH Management in Three Countries
|
N/A | |
Not yet recruiting |
NCT02853552 -
Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
|
Phase 4 | |
Completed |
NCT02805426 -
Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage
|
Phase 4 |